Table 2.
Details of major complications after SRFA
| Patient | Age | Sex | Primary tumor | Cirr. | Tumors/session | Lesion size (max/session) | Needles/session | Complication | Therapy | Related to H.D. |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 53 | Male | HCC | Yes | 2 | 5.0 cm, (5.0 cm) | 16 | Liver failure | Acute LTX | Yes |
| 2 | 48 | Male | HCC | No | 1 | 6.4 cm, (6.4) | 12 | ARDS, pleural effusion | ICU, drainage | Yes |
| 3 | 73 | Female | HCC | Yes | 1 | 1.1 cm | 3 | Diaphragmatic defect | Surgery | Yes |
| 4 | 47 | Male | NET | No | 2 | 3.5 cm, (3.5) | 6 | Diaphragmatic hernia | Surgery | Yes |
| 5 | 68 | Female | OVC | No | 2 | 2.8 cm, (2.8) | 6 | Bowel thermal damage | Surgery | No |
| 6 | 77 | Male | CRC | No | 3 | 5.5 cm, (5.5) | 12 | Perihepatic bleeding, hemorrhagic shock w. death | AG-coiling, ICU | Yes |
| 7 | 69 | Male | CRC | No | 1 | 7.2 cm | 10 | Pneumothorax | Chest-tube | Yes |
| 8 | 61 | Male | CRC | No | 2 | 4.0 cm, (4.0) | 8 | Pneumothorax | Chest-tube | Yes |
| 9 | 61 | Female | CRC | No | 5 | 5.0 cm, (5.0) | 22 | Pneumothorax | Chest-tube | Yes |
| 10 | 70 | Male | HCC | Yes | 1 | 7.0 cm | 9 | Pneumothorax | Chest-tube | Yes |
| 11 | 69 | Male | HCC | Yes | 3 | 4.0 cm, (4.0) | 14 | Pneumothorax | Chest-tube | Yes |
| 12 | 38 | Male | CRC | No | 5 | 1.0 cm | 14 | Perihepatic bleeding | AG-coiling | No |
| 13 | 72 | Male | ESC | No | 1 | 1.5 cm | 5 | Perihepatic bleeding | AG-coiling | Yes |
| 14 | 51 | Male | HCC | Yes | 1 | 1.5 cm | 3 | Perihepatic bleeding | AG-coiling | Yes |
| 15 | 72 | Male | CRC | No | 4 | 2.0 cm, (2.1) | 15 | Perihepatic bleeding | AG-coiling | Yes |
| 16 | 46 | Female | OVC | No | 2 | 3.0, (3.0) | 7 | Perihepatic bleeding | AG-coiling | Yes |
| 17 | 63 | Male | HCC | Yes | 2 | 2.0 cm, (2.7) | 4 | Intrahepatic bleeding | AG-coiling | Yes |
| 18 | 63 | Male | HCC | Yes | 1 | 2.2 cm | 3 | Perihepatic bleeding | AG-coiling | Yes |
| 19 | 48 | Male | HCC | No | 3 | 2.0 cm, (3.0) | 9 | Perihepatic bleeding | AG-coiling | No |
| 20 | 7 | Female | NBL | No | 1 | 3.5 cm | 6 | Intrahepatic bleeding | AG-coiling | Yes |
| 21 | 67 | Male | HCC | Yes | 2 | 1.6 cm, (1,8 cm) | 6 | Pleural effusion | ICU, drainage | Yes |
| 22 | 56 | Male | HCC | Yes | 3 | 2.8 cm (2.8 cm) | 10 | Pleural effusion | Drainage (US-guided) | Yes |
| 23 | 60 | Male | CRC | No | 1 | 3.0 cm | 10 | Pleural effusion | Drainage (US-guided) | Yes |
| 24 | 68 | Male | MEL | No | 1 | 5.5 cm | 8 | Pleural effusion | Drainage (US-guided) | Yes |
| 25 | 58 | Male | HCC | Yes | 2 | 8.5 cm, (8.5) | 18 | Pleural effusion | Drainage (US-guided) | Yes |
SRFA stereotactic radiofrequency ablation, HCC hepatocellular carcinoma, CRC colorectal carcinoma, MEL melanoma, NBL neuroblastoma, NET neuroendrocrine tumor, OVC ovarian cancer, ESC esophageal cancer, Cirr hepatic cirrhosis, ICU intensive care unit, AG angiography, LTX liver transplantation, H.D. hepatic dome